Ruben Mesa, MD from UT Health San Antonio Cancer Center discusses impact of immune-based therapies and great impact on lymphoid malignancies at the 2017 American Society of Hematology.
Impact of Immune-based Therapies – Great impact on lymphoid malignancies
